☰

Philip M. Bauer, Ph.D.

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
regulation and modulation of nitric oxide (NO) production and cytotoxicity in macrophages, vascular cells, and tumor cells
Google:
"Philip Bauer"
Mean distance: 15.03
 		SNBCP
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Louis J. Ignarro grad student 2001 UCLA
 (The inhibition of ornithine decarboxylase by nitric oxide: Biochemical mechanisms and physiological implications.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Song GJ, Leslie KL, Barrick S, et al. (2015) Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2). The Journal of Biological Chemistry. 290: 2879-87
Bauer EM, Shapiro R, Billiar TR, et al. (2013) High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s). The Journal of Biological Chemistry. 288: 1365-73
Yu J, Zhang Y, Zhang X, et al. (2012) Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodeling. Plos One. 7: e31495
Song GJ, Barrick S, Leslie KL, et al. (2012) The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 33-41
Gangopahyay A, Oran M, Bauer EM, et al. (2011) Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation. The Journal of Biological Chemistry. 286: 33134-40
Bernatchez P, Sharma A, Bauer PM, et al. (2011) A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. The Journal of Clinical Investigation. 121: 3747-55
Bauer EM, Qin Y, Miller TW, et al. (2010) Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovascular Research. 88: 471-81
Rodriguez AI, Gangopadhyay A, Kelley EE, et al. (2010) HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 98-104
Li L, Hisamoto K, Kim KH, et al. (2007) Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proceedings of the National Academy of Sciences of the United States of America. 104: 16468-73
Bernatchez PN, Bauer PM, Yu J, et al. (2005) Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proceedings of the National Academy of Sciences of the United States of America. 102: 761-6
See more...